Navigation Links
Rigel to Present at Bank of America Merrill Lynch Health Care Conference
Date:5/5/2011

SOUTH SAN FRANCISCO, Calif., May 5, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Ryan Maynard, the company's chief financial officer, is scheduled to present a company overview at the Bank of America Merrill Lynch Health Care Conference in Las Vegas on Tuesday, May 10th at 10:00 a.m. PT.

(Logo: http://photos.prnewswire.com/prnh/20030226/RIGLLOGO)

The presentation will be webcast live and can be accessed at www.rigel.com.  Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Rigel's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market its product candidates. Current product development programs include fostamatinib, an oral syk inhibitor that has started its phase 3 clinical trial program for rheumatoid arthritis, and R343, an inhaled syk inhibitor that has completed Phase 1 clinical trials for asthma.

Contact: Ryan Maynard
Phone: 650.624.1284
Email: invrel@rigel.com


'/>"/>
SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Rigel Announces First Quarter Financial Results
2. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
3. Rigel to Present at Three Upcoming Investor Conferences
4. Rigel Announces Participation at Two Investor Conferences
5. Rigel to Present at JP Morgan Healthcare Conference
6. Rigel Announces Third Quarter 2009 Financial Results
7. Rigel Announces Presentations at Two Investor Conferences
8. Rigels R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
9. Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis
10. Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas
11. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... Research and Markets has announced the ... the USA"  report to their offering.  ,     (Logo: ... current Positron Emission Tomography (PET) scanner and cyclotron install ... Along with the current known number of PET scanners ... the report also contains a detailed breakdown of this ...
(Date:5/5/2016)... 5, 2016 ... of the  "Europe Thrombocythemia Market and ... to their offering.       ... ,The latest research Europe Thrombocythemia Market ... provides comprehensive insights into Thrombocythemia pipeline ...
(Date:5/5/2016)... , May 5, 2016 ... addition of the  "Europe Thalassaemia Market and ... their offering.       (Logo: ... Europe Thalassaemia Market and Competitive Landscape Highlights ... pipeline products, Thalassaemia epidemiology, Thalassaemia market valuations ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... 05, 2016 , ... Derrin Doty Group has unveiled the latest charity campaign ... communities west of Seattle. The insurance provider’s caring team has been so moved by ... due to complications from the flu, that they have decided to extend their original ...
(Date:5/5/2016)... ... May 05, 2016 , ... The University of ... to host the 2016 National SACA Leadership Conference on the Portland campus September ... chapter officers to come together and develop skills to be future leaders in ...
(Date:5/5/2016)... ... , ... Vitenas Cosmetic Surgery has been named as one of the eight ... Architects and the Academy of Architecture for Health. The building, brainchild of founder Paul ... patients in October of 2014. , The prestigious Healthcare Design Awards ...
(Date:5/5/2016)... ... May 05, 2016 , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, ... Dr. Stong is double board certified and the only facial plastic surgeon in Atlanta ... loss. Non-surgical therapies such as stem cells can be used to provide stabilization to ...
(Date:5/5/2016)... ... 05, 2016 , ... In honor of National Nurses Week 2016, Aya ... United States to thank a nurse who's made a difference in their life. From ... American Red Cross of San Diego/Imperial Counties (up to $10,000) every time someone tells ...
Breaking Medicine News(10 mins):